The global 3D cell culture market size was estimated at USD 1.57 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.22% from 2024 to 2030. The growth of the market can be attributed to the rising efforts to develop potential alternatives to animal-based testing and the availability of funding programs for research. Moreover, consistent efforts in R&D...

The global cancer stem cells market size is expected to reach USD 5.55 billion by 2030, registering a CAGR of 9.6% from 2024 to 2030, as per the new report by Grand View Research, Inc. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D...

The global molecular cytogenetics market was valued at USD 2.02 billion in 2022, and it is projected to grow at a compound annual growth rate (CAGR) of 10.6% from 2023 to 2030. This substantial growth is driven by several key factors, including the increasing incidence of oncology cases, ongoing technological advancements in chromosome analysis tools, and the growing shift toward...

The global preparative and process chromatography market was valued at USD 9.5 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.08% during the forecast period. Several factors are contributing to the growth of this market, particularly the increasing demand for and approval of monoclonal antibodies in the pharmaceutical and biotechnology sectors....

Molecular Cytogenetics Industry The global molecular cytogenetics market size is anticipated to reach USD 4.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.6% from 2023 to 2030. Rising penetration of molecular cytogenetics in clinical pathological testing, growing inclination towards targeted cancer treatment, and...

Molecular Cytogenetics Industry The global molecular cytogenetics market size is anticipated to reach USD 4.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 10.6% from 2023 to 2030. Rising penetration of molecular cytogenetics in clinical pathological testing, growing inclination towards targeted cancer treatment, and...

The global regenerative medicine market size is expected to reach USD 90.01 billion by 2030, expanding at a CAGR of 16.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. The presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in R&D to upgrade their products with the latest technology...